Copyright
©The Author(s) 2025.
World J Transplant. Jun 18, 2025; 15(2): 99208
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.99208
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.99208
Table 1 CAR-OLT score components in our cohort, n (%)
Pretransplant risk factors | Entire cohort (n = 342) | Missing data |
Age group | None | |
< 45 | 31 (9) | |
45-49 | 29 (8.5) | |
50-54 | 49 (14.3) | |
55-59 | 73 (21.3) | |
60-64 | 83 (24.3) | |
65+ | 77 (22.5) | |
Sex | ||
Men | 276 (80.7) | |
Women | 66 (19.3) | None |
Race | ||
White | 333 (97.4) | |
Black | 5 (1.5) | |
Others | 4 (1.1) | |
Working status | ||
Working for income | 149 (43.6) | None |
Not working for income | 193 (56.4) | None |
Education | ||
≤ High school | 326 (95.3) | |
College+ | 16 (4.7) | |
Atrial fibrillation | ||
Yes | 16 (4.7) | |
No | 326 (95.3) | None |
Respiratory failure on ventilator at transplant | ||
Yes | 1 (0.3) | |
No | 341 (99.7) | None |
Pulmonary hypertension | ||
Yes | 11 (3.2) | |
No | 331 (96.8) | |
Hepatocellular carcinoma | ||
Yes | 158 (46.2) | |
No | 184 (53.8) | |
Hypertension | ||
Yes | 118 (34.5) | |
No | 224 (65.5) | None |
Diabetes | ||
Yes | 128 (37.4) | |
No | 214 (62.6) | None |
Heart failure | ||
Yes | 16 (4.7) | |
No | 326 (95.3) | None |
Table 2 Cardiac workup and pharmacoeconomic analysis1, n (%)
Variable | Entire cohort (n = 342) | Patients with CAR-OLT scores ≤ 23 (n = 84) | Potential saving (€) | Potential saving (€) per patient |
Exercise electrocardiogram | ||||
Tests performed | 54/342 (15.8) | 18/84 (21.4) | 1004.40 | 11.95 |
Doubtful/positive result (on valid tests) | 9/44 (20.4) | 5/13 (38.5) | ||
Stress myocardial perfusion imaging | ||||
Tests performed | 206/342 (60.2) | 58/84 (69) | 17864 | 212.66 |
Doubtful/positive result | 68/206 (33) | 12/58 (20.7) | ||
Stress echocardiogram | ||||
Test performed | 14/342 (4.1) | 2/84 (2.4) | 140€ | 1.66€ |
Doubtful/positive result | 1/14 (7.1) | 0 | ||
Coronary computed tomography angiography | ||||
Tests performed | 34/342 (9.9) | 9/84 (10.7) | 1422€ | 16.93€ |
Significant stenosis | 4/34 (11.8) | 1/9 (11.1) | ||
Coronary angiography | ||||
Test performed | 80/342 (23.4) | 13/84 (15.5) | 27846€ | 331.5€ |
Significant stenosis | 25/80 (31.2) | 3/13 (23.1) | ||
1 vessel | 10 | 1 | ||
2 vessels | 9 | 0 | ||
3 vessels | 6 | 2 | ||
Myocardial revascularization | ||||
Percutaneous coronary intervention | 11 | 1 | ||
Coronary artery bypass | 1 | 1 | ||
Right heart catheterization | 11 | 1 | - | |
Cardiac contraindications to listing | 21/342 (6.1) | 2/84 (2.4) | ||
Coronary artery disease | 10 | 1 | ||
Valvular heart disease | 4 | 0 | ||
Severe pulmonary hypertension | 3 | 1 | ||
Atrial fibrillation associated with left ventricular ejection fraction < 45% | 4 | 0 | ||
Overall diagnostic work-up | 388 diagnostic exams | 100 diagnostic exams | 48276.40€ | 574.70€ |
- Citation: Biolato M, Miele L, Avolio AW, Marrone G, Liguori A, Galati F, Petti A, Tomasello L, Pedicino D, Lombardo A, D'Aiello A, Pompili M, Agnes S, Gasbarrini A, Grieco A. Diagnostic accuracy and cost-effectiveness of the CAR-OLT score in predicting cardiac risk for liver transplantation. World J Transplant 2025; 15(2): 99208
- URL: https://www.wjgnet.com/2220-3230/full/v15/i2/99208.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i2.99208